Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain.
about
A structural and mutagenic blueprint for molecular recognition of strychnine and d-tubocurarine by different cys-loop receptorsEnd-plate acetylcholine receptor: structure, mechanism, pharmacology, and diseaseConformational Remodeling of Femtomolar Inhibitor−Acetylcholinesterase Complexes in the Crystalline State[(3)H]Epibatidine photolabels non-equivalent amino acids in the agonist binding site of Torpedo and alpha4beta2 nicotinic acetylcholine receptorsThe kinetics of competitive antagonism of nicotinic acetylcholine receptors at physiological temperature.Control of cation permeation through the nicotinic receptor channelLigand-induced conformational change in the alpha7 nicotinic receptor ligand binding domainRoles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists.Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.Structural answers and persistent questions about how nicotinic receptors work.Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors.High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine ReceptorSynergy between pairs of competitive antagonists at adult human muscle acetylcholine receptors.Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: a computational and experimental study using epibatidine-related molecular probes.Agonist-mediated conformational changes in acetylcholine-binding protein revealed by simulation and intrinsic tryptophan fluorescence.
P2860
Q21145775-E9FFE2E8-82E8-4520-996D-1C5390F034B6Q24618824-3A0FFCB3-3970-4574-9B4F-3A05BC644B72Q27665972-7D1BED28-643C-488B-A1F6-38045CED53A1Q30379087-490075AB-A32D-4653-9492-DDD9EB7AAA9AQ30445169-F3C30685-1057-46AF-AD11-3F6F55AFE1C0Q33320186-CF1C407A-D25D-4A4B-BFBB-08CA503D40ADQ34189724-8387EA33-56E4-443A-BE2A-833D6AB987D3Q34654180-7E3ABBAA-DA87-4D4C-AF03-F1CEDABCE54CQ34657342-EDDA2225-2382-4531-AD27-14204FA0F8F5Q34782188-F1E8B81F-62D9-4F91-A970-493BA298B763Q35795255-476516D0-49DC-416C-A762-E260784FDA11Q36138522-8EA75B69-5C15-4454-A3A1-0D9009808EAFQ36813566-6294AC99-B0D7-41E8-9503-B8AD0E63D76AQ44895743-46F4300A-D70C-422E-9092-8B4C69A393B1Q45182660-D72B6275-44E9-4BFE-B840-C7923E7F4E39
P2860
Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Curariform antagonists bind in ...... eceptor ligand binding domain.
@en
type
label
Curariform antagonists bind in ...... eceptor ligand binding domain.
@en
prefLabel
Curariform antagonists bind in ...... eceptor ligand binding domain.
@en
P2093
P2860
P356
P1476
Curariform antagonists bind in ...... eceptor ligand binding domain.
@en
P2093
Hai-Long Wang
Steven M Sine
P2860
P304
32284-32291
P356
10.1074/JBC.M304366200
P407
P577
2003-06-10T00:00:00Z